Sagittal abdominal diameter is a strong anthropometric marker of insulin resistance and hyperproinsulinemia in obese men.

OBJECTIVE It is clinically important to find noninvasive markers of insulin resistance and hyperproinsulinemia because they both predict cardiovascular and diabetes risk. Sagittal abdominal diameter (SAD) or "supine abdominal height" is a simple anthropometric measure previously shown to predict mortality in men, but its association with insulin resistance and hyperproinsulinemia is unknown. RESEARCH DESIGN AND METHODS In a common high-risk group of 59 moderately obese men (aged 35-65 years, BMI 32.6 +/- 2.3 kg/m(2)), we determined anthropometry (SAD, BMI, waist girth, and waist-to-hip ratio [WHR]); insulin sensitivity (euglycemic-hyperinsulinemic clamp); and plasma concentrations of intact proinsulin, specific insulin, C-peptide, glucose, and serum IGF binding protein-1 (IGFBP-1). To compare SAD with other anthropometric measures, univariate and multiple regression analyses were used to determine correlations between anthropometric and metabolic variables. RESULTS SAD showed stronger correlations to all measured metabolic variables, including insulin sensitivity, than BMI, waist girth, and WHR. SAD explained the largest degree of variation in insulin sensitivity (R(2) = 0.38, P < 0.0001) compared with other anthropometric measures. In multiple regression analyses, including all anthropometric measures, SAD was the only independent anthropometric predictor of insulin resistance (P < 0.001) and hyperproinsulinemia (P < 0.001). CONCLUSIONS In obese men, SAD seems to be a better correlate of insulin resistance and hyperproinsulinemia (i.e., cardiovascular risk) than other anthropometric measures. In overweight and obese individuals, SAD could represent a simple, cheap, and noninvasive tool that could identify the most insulin resistant in both the clinic and clinical trials evaluating insulin sensitizers. These results need confirmation in larger studies that also include women and lean subjects.

[1]  M. Visser,et al.  Abdominal diameters as indicators of visceral fat: comparison between magnetic resonance imaging and anthropometry , 1993, British Journal of Nutrition.

[2]  R. Haase,et al.  Multivariate analysis of variance. , 1987 .

[3]  S. Kahn,et al.  Proinsulin as a Marker for the Development of NIDDM in Japanese-American Men , 1995, Diabetes.

[4]  C. Berne,et al.  Proinsulin Is an Independent Predictor of Coronary Heart Disease: Report From a 27-Year Follow-Up Study , 2002, Circulation.

[5]  A. Angel.  Progress in Obesity Research: 7 , 1996 .

[6]  A. Kissebah.  Insulin resistance in visceral obesity. , 1991, International journal of obesity.

[7]  S. O’Rahilly,et al.  The perils of portliness: causes and consequences of visceral adiposity. , 2000, Diabetes.

[8]  R. Young,et al.  Reduced insulin-like growth factor binding protein-1 (IGFBP-1) levels correlate with increased cardiovascular risk in non-insulin dependent diabetes mellitus (NIDDM). , 1996, The Journal of clinical endocrinology and metabolism.

[9]  C. Bouchard,et al.  The use of anthropometric and dual-energy X-ray absorptiometry (DXA) measures to estimate total abdominal and abdominal visceral fat in men and women. , 1999, Obesity research.

[10]  L. Berglund,et al.  Sagittal abdominal diameter compared with other anthropometric measurements in relation to cardiovascular risk , 2000, International Journal of Obesity.

[11]  E. Ferrannini,et al.  Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). , 1997, The Journal of clinical investigation.

[12]  W. Dietz,et al.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.

[13]  L. Lönn,et al.  The sagittal diameter is valid marker of the visceral adipose tissue volume , 1996 .

[14]  S. B. Pedersen,et al.  Associations between different anthropometric measurements of fatness and metabolic risk parameters in non-obese, healthy, middle-aged men. , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[15]  E. Ravussin,et al.  Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. , 1993, The New England journal of medicine.

[16]  J. Houmard,et al.  Which anthropometric indices of regional adiposity are related to the insulin resistance of aging? , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[17]  L. Riste,et al.  Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations , 2001, Diabetologia.

[18]  Leonard H. Epstein,et al.  Overweight, obesity, and health risk. , 2000, Archives of internal medicine.

[19]  M. Trevisan,et al.  Altered renal sodium handling in men with abdominal adiposity: a link to hypertension , 2001, Journal of hypertension.

[20]  Kahn Hs,et al.  Sagittal abdominal diameter. , 1993 .

[21]  L. Groop,et al.  Metabolic Consequences of a Family History of NIDDM (The Botnia Study): Evidence for Sex-Specific Parental Effects , 1996, Diabetes.

[22]  D. F. Morrison,et al.  Multivariate Statistical Methods , 1968 .

[23]  Tracey McLaughlin,et al.  Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant , 2003, Annals of Internal Medicine.

[24]  C. Bouchard,et al.  Major gene for abdominal visceral fat area in the Québec Family Study. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[25]  G. Hitman,et al.  Familial aggregation of central obesity in Southern Indians , 2000, International Journal of Obesity.

[26]  J. Sorkin,et al.  The sagittal waist diameter and mortality in men: the Baltimore Longitudinal Study on Aging. , 1994, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[27]  H Austin,et al.  Simple anthropometric indices associated with ischemic heart disease. , 1996, Journal of clinical epidemiology.

[28]  E. Simões,et al.  The abdominal diameter index and sudden coronary death in men. , 1996, The American journal of cardiology.

[29]  L. Lissner,et al.  Relationships between changes in body composition and changes in cardiovascular risk factors: the SOS Intervention Study. Swedish Obese Subjects. , 1997, Obesity research.

[30]  T. Quertermous,et al.  Sagittal abdominal diameter is associated with insulin sensitivity in Chinese hypertensive patients and their siblings , 2003, Journal of Human Hypertension.

[31]  K. Asayama,et al.  Threshold values of visceral fat measures and their anthropometric alternatives for metabolic derangement in Japanese obese boys , 2002, International Journal of Obesity.

[32]  C. Berne,et al.  Proinsulin and acute insulin response independently predict Type 2 diabetes mellitus in men—report from 27 years of follow-up study , 2003, Diabetologia.

[33]  S. Grundy,et al.  Relationships of generalized and regional adiposity to insulin sensitivity in men. , 1995, The Journal of clinical investigation.

[34]  T. McLaughlin,et al.  Beyond type 2 diabetes: the need for a clinically useful way to identify insulin resistance. , 2003, The American journal of medicine.

[35]  L. Sjöström,et al.  Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations. , 1988, The American journal of clinical nutrition.

[36]  D. Williamson,et al.  Sagittal abdominal diameter. , 1993, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[37]  A Tremblay,et al.  Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. , 1994, The American journal of cardiology.

[38]  J. Després,et al.  Treatment of obesity: need to focus on high risk abdominally obese patients , 2001, BMJ : British Medical Journal.

[39]  J. Seidell,et al.  Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample , 1995, BMJ.

[40]  V. Grill,et al.  The insulin-like growth factor binding protein-1 in low and high insulin responders before and during dexamethasone treatment. , 1991, Metabolism: clinical and experimental.

[41]  K. Hall,et al.  Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. , 1984, Acta endocrinologica.

[42]  M. Laakso,et al.  Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects , 1995, Diabetologia.

[43]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[44]  P. Elwood,et al.  Concentrations of proinsulin like molecules predict coronary heart disease risk independently of insulin: prospective data from the Caerphilly Study , 2002, Diabetologia.

[45]  P. Arner,et al.  Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. , 2002, Diabetes care.

[46]  M. Staten,et al.  Insulin Resistance in Aging Is Related to Abdominal Obesity , 1993, Diabetes.

[47]  B. Egan,et al.  Insulin resistance and cardiovascular disease. , 2001, American journal of hypertension.

[48]  G. Berenson,et al.  Relation of abdominal height to cardiovascular risk factors in young adults: the Bogalusa heart study. , 2000, American journal of epidemiology.

[49]  R. Bergman,et al.  Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. , 2003, Diabetes.

[50]  L. Giudice,et al.  Insulinlike growth factor-binding proteins. , 1990, Recent progress in hormone research.

[51]  G. Reaven.  Metabolic Syndrome: Pathophysiology and Implications for Management of Cardiovascular Disease , 2002, Circulation.

[52]  L. Berglund,et al.  Reliability of anthropometric measurements in overweight and lean subjects: consequences for correlations between anthropometric and other variables , 2000, International Journal of Obesity.

[53]  Després Jp.  Abdominal obesity as important component of insulin-resistance syndrome. , 1993, Nutrition.